Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 01, 2022

SELL
$56.6 - $89.9 $436,216 - $692,859
-7,707 Closed
0 $0
Q1 2022

Apr 11, 2022

BUY
$60.15 - $84.52 $463,576 - $651,395
7,707 New
7,707 $639,000
Q4 2021

Feb 09, 2022

SELL
$75.08 - $121.99 $578,641 - $940,176
-7,707 Closed
0 $0
Q3 2021

Oct 29, 2021

BUY
$116.17 - $194.55 $895,322 - $1.5 Million
7,707 New
7,707 $893,000
Q2 2021

Jul 13, 2021

SELL
$130.4 - $225.58 $1 Million - $1.74 Million
-7,707 Closed
0 $0
Q1 2021

May 10, 2021

BUY
$124.11 - $190.17 $754,216 - $1.16 Million
6,077 Added 372.82%
7,707 $1.02 Million
Q4 2020

Feb 04, 2021

BUY
$112.16 - $174.14 $182,820 - $283,848
1,630 New
1,630 $262,000

Others Institutions Holding NVCR

About NovoCure Ltd


  • Ticker NVCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 104,950,000
  • Market Cap $3.25B
  • Description
  • NovoCure Limited, an oncology company, engages in the development, manufacture, and commercialization of tumor treating fields (TTFields) devices for the treatment of solid tumor cancers in the United States, Europe, the Middle East, Africa, Japan, and Greater China. Its TTFields devices include Optune for the treatment of glioblastoma; and Optu...
More about NVCR
Track This Portfolio

Track Maryland State Retirement & Pension System Portfolio

Follow Maryland State Retirement & Pension System and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Maryland State Retirement & Pension System, based on Form 13F filings with the SEC.

News

Stay updated on Maryland State Retirement & Pension System with notifications on news.